|
|
|
|
EVM005: An Ectromelia-Encoded Protein with Dual Roles in NF-κB Inhibition and Virulence
|
|
|
|
|
|
|
|
نویسنده
|
van buuren n. ,burles k. ,schriewer j. ,mehta n. ,parker s. ,buller r.m. ,barry m.
|
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 8
|
|
چکیده
|
Poxviruses contain large dsdna genomes encoding numerous open reading frames that manipulate cellular signalling pathways and interfere with the host immune response. the nf-κb signalling cascade is an important mediator of innate immunity and inflammation,and is tightly regulated by ubiquitination at several key points. a critical step in nf-κb activation is the ubiquitination and degradation of the inhibitor of kappab (iκbα),by the cellular scfβ-trcp ubiquitin ligase complex. we show here that upon stimulation with tnfα or il-1β,orthopoxvirus-infected cells displayed an accumulation of phosphorylated iκbα,indicating that nf-κb activation was inhibited during poxvirus infection. ectromelia virus is the causative agent of lethal mousepox,a natural disease that is fatal in mice. previously,we identified a family of four ectromelia virus genes (evm002,evm005,evm154 and evm165) that contain n-terminal ankyrin repeats and c-terminal f-box domains that interact with the cellular scf ubiquitin ligase complex. since degradation of iκbα is catalyzed by the scfβ-trcp ubiquitin ligase,we investigated the role of the ectromelia virus ankyrin/f-box protein,evm005,in the regulation of nf-κb. expression of flag-evm005 inhibited both tnfα- and il-1β-stimulated iκbα degradation and p65 nuclear translocation. inhibition of the nf-κb pathway by evm005 was dependent on the f-box domain,and interaction with the scf complex. additionally,ectromelia virus devoid of evm005 was shown to inhibit nf-κb activation,despite lacking the evm005 open reading frame. finally,ectromelia virus devoid of evm005 was attenuated in both a/ncr and c57bl/6 mouse models,indicating that evm005 is required for virulence and immune regulation in vivo. © 2014 van buuren et al.
|
|
|
|
|
آدرس
|
li ka shing institute of virology,department of medical microbiology and immunology,university of alberta,edmonton,ab, Canada, li ka shing institute of virology,department of medical microbiology and immunology,university of alberta,edmonton,ab, Canada, department of molecular microbiology and immunology,saint louis university school of medicine,st. louis,mo, United States, li ka shing institute of virology,department of medical microbiology and immunology,university of alberta,edmonton,ab, Canada, department of molecular microbiology and immunology,saint louis university school of medicine,st. louis,mo, United States, department of molecular microbiology and immunology,saint louis university school of medicine,st. louis,mo, United States, li ka shing institute of virology,department of medical microbiology and immunology,university of alberta,edmonton,ab, Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|